Global Development
- we develop products that make a difference
In Global Development we create new products based on proteins and peptides and take responsibility for these from early development phases to product introduction. It takes about 10-13 years to move from idea to patient and in Global Development we are responsible for preclinical tests, clinical trials and project management – which all are key elements in this long and complex process.
Our global reach and focus
We are responsible for managing all global drug development projects world-wide across all therapeutic areas, securing that the process live up to uniform global standards, regulations and business ethics. We work in global project teams with focus on delivering viable products that benefit society and make a difference.
In our preclinical development projects we perform screening and selection of new drug candidates from research projects to the delivery for further clinical development. Our 4 main preclinical development project areas are within diabetes, haemostasis, growth hormone and inflammation.
In our clinical development projects we develop the drugs and document their effectiveness and safety through clinical trials. This process takes approximately 5-7 years and we conduct trials in over 50 countries and approximately 15,000-25,000 patients a year participate in these clinical trials. The trials are listed at our clinical trials web-site providing an overview of all our activities worldwide. To ensure best practice, skills and knowledge in the development of therapies, we work with the world’s leading academic centres and preferred industrial partners and our clinical trials are conducted out of Clinical Development Centres in North America, Europe, Japan and China. People participating in Novo Nordisk trials are protected by the same rights, high ethical standards and regulations irrespective of the location of the study as the same procedure is applied in all trials all over the world.
See our other units in R&D
Diabetes Research Unit
Biopharmaceutical Research Unit
Device R&D
Regulatory Affairs
CMC Supply
